Real-World Treatment Patterns for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer in Europe and the United States
Open Access
- 27 October 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncology and Therapy
- Vol. 4 (2), 189-197
- https://doi.org/10.1007/s40487-016-0033-z
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Treatment patterns and duration in post-menopausal women with HR+/HER2− metastatic breast cancer in the US: a retrospective chart review in community oncology practices (2004–2010)Current Medical Research and Opinion, 2014
- ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)Annals Of Oncology, 2014
- Real-world patterns of endocrine therapy for metastatic hormone-receptor-positive (HR+)/human epidermal growth factor receptor-2-negative (HER2−) breast cancer patients in the United States: 2002–2012Current Medical Research and Opinion, 2014
- Disease management patterns for postmenopausal women in Europe with hormone-receptor-positive, human epidermal growth factor receptor-2 negative advanced breast cancerCurrent Medical Research and Opinion, 2014
- The development of endocrine therapy for women with breast cancerCancer Treatment Reviews, 2013